Back to User profile » Dr Heng Xu
Papers published by Dr Heng Xu:
Lower Serum Matrix Metalloproteinase‑9 in Metastatic Patients with Esophageal Squamous Cell Carcinoma After Concurrent Radiotherapy Was Significant for Prognosis
Ye Z, Zhao H, Zhou W, Ye T, Geng C, Li X, Yuan L, Du M, Xu H, Wang Q
OncoTargets and Therapy 2020, 13:12857-12866
Published Date: 15 December 2020
Relevance of EGFR Between Serum VEGF and MMP-9 in Primary Hepatocellular Carcinoma Patients with Transarterial Chemoembolization
Cao S, Zhu S, Yin W, Xu H, Wu J, Wang Q
OncoTargets and Therapy 2020, 13:9407-9417
Published Date: 23 September 2020
Serum Platelet-Derived Growth Factor Is Significantly Lower in Patients with Lung Cancer and Continued to Decrease After Platinum-Based Chemotherapy
Ma R, Yang Q, Cao S, Liu S, Cao H, Xu H, Wu J, Feng J
OncoTargets and Therapy 2020, 13:1883-1892
Published Date: 4 March 2020
Monoclonal antibody AC10364 inhibits cell proliferation in 5-fluorouracil resistant hepatocellular carcinoma via apoptotic pathways
Wu J, Qu J, Cao H, Jing C, Wang Z, Xu H, Ma R
OncoTargets and Therapy 2019, 12:5053-5067
Published Date: 28 June 2019